Back to comparisons

Comparison

Rhodiola Rosea vs Kava

FieldRhodiola RoseaKava
Categoryadaptogenadaptogen
Dose range200–400mg100–300mg
Half-life4h9h
Onset
EvidenceEVIDENCEAEVIDENCEA
Safety●●●●●●●○○○
Legal (US)USOTCUSOTC
PubMed refs460600

The comparison in plain English

Auto-generated from data

Rhodiola Rosea and Kava are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. Kava South Pacific root (Piper methysticum) used for anxiety and social relaxation.

Bottom line

Rhodiola Rosea (evidence A, safety 5/5) matches the evidence base of Kava (evidence A, safety 2/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Choose Kava if

Kava is the better fit when your goal aligns with its mechanism (Kavalactones — particularly kavain, methysticin, and yangonin — bind GABA-A receptors at a site distinct from benzodiazepines, plus modulate dopamine and noradrenergic systems) and the dose range (100–300mg) suits your protocol. Half-life is 9h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →